Document is current
Any future updates will be listed below
-
Authors
Slotman, Derk J. https://orcid.org/0000-0002-3358-1986
Bartels, Marcia M. T. J.
Ferrer, Cyril J.
Bos, Clemens
Bartels, Lambertus W.
Boomsma, Martijn F.
Phernambucq, Erik C. J.
Nijholt, Ingrid M.
Morganti, Alessio G.
Siepe, Giambattista
Buwenge, Milly
Grüll, Holger
Bratke, Grischa
Yeo, Sin Yuin
Blanco Sequeiros, Roberto
Minn, Heikki
Huhtala, Mira
Napoli, Alessandro
De Felice, Francesca
Catalano, Carlo
Bazzocchi, Alberto
Gasperini, Chiara
Campanacci, Laura
Simões Corrêa Galendi, Julia
Müller, Dirk
Braat, Manon N. G. J. A.
Moonen, Chrit
Verkooijen, Helena M.
,
-
Funding
Funding for this research was provided by:
Horizon 2020 (825859)
- License Information
-
More Information
Article History
Received: 6 July 2022
Accepted: 17 November 2022
First Online: 29 December 2022
Declarations
:
: The Medical Ethical Research Committee from the University Medical Center Utrecht approved this study. Written, informed consent to participate will be obtained from all participants (Dutch version in Supplementary Material, an English version can be acquired upon request). The informed consent document contains an option for the patient to approve the use of their data for future research in the field of treatments of bone metastasis pain during 15 years. The FURTHER-consortium intends to use the trial data from patients who approved this for the development of an MR-HIFU-outcome prediction tool.
: Not applicable.
: All authors report financial support of the European Union’s Horizon 2020 program for submitted work. Prof. Dr. Verkooijen reports grants from Elekta and Dutch Cancer Society, outside of the submitted work. Prof. Morganti reports grants from Elekta, IGEA, Astellas, Alfasigma, Bayer, and Thema Sinergie outside the submitted work. Dr. Sin Yuin Yeo has a part-time position with Profound Medical GmbH, outside of the submitted work.
